selected publications
-
Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway.
Antioxidants (Basel, Switzerland).
2023
Academic Article
GET IT
Times cited: 985 -
Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension.
Redox biology.
2021
Academic Article
GET IT
Times cited: 12 -
Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury.
Experimental eye research.
2020
Review
GET IT
Times cited: 7 -
Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy.
Journal of controlled release : official journal of the Controlled Release Society.
2020
Academic Article
GET IT
Times cited: 11 -
Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma.
Neurobiology of disease.
2019
Academic Article
GET IT
Times cited: 15 -
Progression and Pathology of Traumatic Optic Neuropathy From Repeated Primary Blast Exposure.
Frontiers in neuroscience.
2019
Academic Article
GET IT
Times cited: 51